AnalystsDaniel MarkowitzDaniel Markowitz's Stock Forecasts
AnalystsDaniel Markowitz
Analyst Ranking
Top 35%
#1788 out of 5186 analysts
Average Return
+4.09%
Win Rate
68%13 out of 19
Risk vs Reward
Poor
Good
Daniel Markowitz's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Guardant Health IncGH | +60.58% | $63.44 | $101.87 | 2025-10-06 - 2026-01-05 | Buy |
Natera IncNTRA | +48.99% | $138.00 | $205.61 | 2025-07-27 - 2026-02-04 | Buy |
Repligen CorpRGEN | +16.02% | $125.94 | $146.11 | 2025-09-21 - 2026-02-04 | Buy |
Guardant Health IncGH | +10.24% | $92.41 | $101.87 | 2025-10-29 - 2026-01-05 | Buy |
Transmedics Group IncTMDX | +9.42% | $119.15 | $130.37 | 2025-09-15 - 2026-02-04 | Buy |
Daniel Markowitz Analyst Color
Get additional color on Daniel Markowitz's coverage of popular stocks
Daniel Markowitz's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
West Pharmaceutical Services IncWST | 4 | Buy | $320.00 | +34.99% | Maintains | 2 days ago |
Rambus IncRMBS | 3 | Buy | $119.00 | +18.00% | Maintains | 2 days ago |
Bio Techne CorpTECH | 3 | Hold | $62.00 | -9.71% | Downgrades | a month ago |
Guardant Health IncGH | 3 | Hold | $105.00 | -1.08% | Downgrades | a month ago |
Insulet CorpPODD | 1 | Buy | $370.00 | +47.27% | Initiates Coverage On | 2 months ago |
Dexcom IncDXCM | 1 | Hold | $68.00 | -3.98% | Initiates Coverage On | 2 months ago |
Natera IncNTRA | 2 | Buy | $250.00 | +21.59% | Maintains | 3 months ago |
Repligen CorpRGEN | 4 | Buy | $175.00 | +19.77% | Maintains | 4 months ago |
Inspire Medical Systems IncINSP | 2 | Buy | $125.00 | +83.20% | Maintains | 4 months ago |
Transmedics Group IncTMDX | 1 | Buy | $155.00 | +18.89% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.